BackCM Life Sciences Overview

CM Life Sciences Receivables

CM Life Sciences's receivables is $77M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$76.93M
↑ 67.30% YoYΔ $30.95M vs prior year quarter

Peer average

Loading

CM Life Sciences Receivables History

Loading

CM Life Sciences vs. peers: Receivables Comparison

Loading

CM Life Sciences Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

CM Life Sciences (CMLF) FAQ

As of the most recent data (March 2026), CMLF shows a receivables of $77M. That compares with $46M in the prior-year period — up 67.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMLF's receivables is now $77M (was $46M) — a 67.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether CM Life Sciences is outperforming or lagging.

Tracking CMLF's receivables over time shows whether CM Life Sciences is scaling, shrinking, or reshaping that part of the business. The current reading is $77M That compares with $46M in the prior-year period — up 67.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has CM Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $77M) with ownership activity and broader fundamentals.